Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department

NCT ID: NCT02152176

Last Updated: 2016-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intense acute pain is a common reason for Emergency admittance and its management is one of the major public health goals.

In the recommendations formalized experts, it is recommended to use a protocol titration with morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg) repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30.

Despite these specific recommendations and a broad awareness of the teams, management of pain remains to be improved, the major difficulty of morphine titration at the emergency department being the availability of paramedical personnel to perform revaluations and reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes.

The investigators want to study the self-controlled morphine titration by the patient by a mechanical device for single use (efficacy/safety).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient Controlled Analgesy group

Titration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.

Group Type EXPERIMENTAL

Titration of morphine by Patient Controlled Analgesy

Intervention Type DEVICE

PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.

Control group

titration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Titration of morphine by Patient Controlled Analgesy

PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission to an emergency department
* Acute pain (Visual Analog Scale \> 60)
* Able to assess pain using the numerical scale
* Prescription of morphine titration

Exclusion Criteria

* Physical or mental disorders limiting the understanding and / or use of a PCA
* History of allergy to morphine / hypersensitivity to any component
* Long-term treatment morphine
* Opioid therapy administered prior to inclusion
* Analgesic treatment level 2 (codeine, tramadol, nefopam ...) administered prior to inclusion or planned
* History of Substance Abuse
* Severe respiratory insufficiency
* Severe hepatic impairment
* Head trauma
* Intracranial hypertension
* Uncontrolled epilepsy
* Pregnant or lactating
* Patient jailed
* Incapacitated adult under guardianship
* Incapable of giving informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ROY Pierre-Marie, MD-PhD

Role: STUDY_CHAIR

UH Angers

SCHOTTE Thibault, Physician

Role: PRINCIPAL_INVESTIGATOR

UH Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SCHOTTE Thibault

Angers, , France

Site Status

CHOUKROUN Jacques

Le Mans, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AOI 2013-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.